Growth in X-linked hypophosphatemic rickets

European Journal of Pediatrics

Volumn 166, Issue 4, 2007, Pages 303-309

  Ariceta, Gema ^a   Langman, Craig B ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Growth; rhGH; X linked hypophosphatemic rickets

Indexed keywords

CALCITRIOL; HUMAN GROWTH HORMONE; PHOSPHATE; VITAMIN D;

ADOLESCENT; ADULT; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GROWTH CURVE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SHORT STATURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VITAMIN D RESISTANT RICKETS;

ADOLESCENT; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33847141774     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0357-z     Document Type: Review

References (31)

1. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G (2001) Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 138:236-243
2. Boot AM, Engels MAMJ, Boerma GJM, Krenning EP, de Muinck Keizer-Schrama SMPF (1997) Changes in bone mineral density, body composition, and lipid metabolism during growth hormone treatment in children with GH deficiency. J Clin Endocrinol Metab 82:2423-2428
3. Cameron FJ, Sochett EB, Daneman A, Kooh SW (1999) A trial of growth hormone therapy in well-controlled hypophosphataemic rickets. Clin Endocrinol 50:577-582
4. Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58:329-333
5. Haffner D, Nissel R, Wühl E, Mehls O (2004) Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets. Pediatrics 113:e593-e596
6. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO (2001) Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86:3880-3899
7. Huiming Y, Chaomin W (2005) Recombinant growth hormone therapy for X-linked hypophosphatemia in children. Cochrane Database Syst Rev 2
8. HYP-Consortium (1995) A gene (PHEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136
9. Mahlbacher K, Sicuro A, Gerber H, Hulter HN, Krapf R (1999) Growth hormone corrects acidosis-induced renal nitrogen wasting and renal phosphate depletion and attenuates renal magnesium wasting in humans. Metabolism 48:763-770
10. Mäkitie O, Dora A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591-3597
11. Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ (1996) Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphatemic rickets. Clin Endocrinol 44:687-696
12. Pereira CM, de Andrade CR, Vargas PA, Coletta RD, de Almeida OP, Lopes MA (2004) Dental alterations associated with X-linked hypophosphatemic rickets. J Endod 30:241-245
13. Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whye MP (1992) X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J Bone Miner Res 7:583-597
14. Pronicka E, Popowska E, Rowinska E, Arasimowicz E, Syczewska S, Jurkiewicz D, Lebiedowski M (2004) Anthropometric characteristics of X-linked hypophosphatemia. Am J Med Gen 126A:141-149
15. Quarles LD (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1-E9
16. Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JHH, Brodehl (1990) X-linked hypophosphatemia: treatment, height gain and nephrocalcinosis. Arch Dis Child 65:1125-1128
17. Reusz G, Miltenyi G, Stubnya G, Szabo A, Horvath C, Byrd DJ, Peter F, Tulassay T (1997) X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone. Pediatr Nephrol 11:573-577
18. Saggese G, Baroncelli G, Bertelloni S, Perri G (1995) Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. J Pediatr 127:395-402
19. Saito H, Maeda A, Ohtomo SI, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto KI, Fukushima N (2005) Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543-2549
20. Schiavi SC, Kumar R (2004) The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 65:1-14
21. Schmitt CP, Mehls O (2004) The enigma of hyperparathyroidism in hypophosphatemic rickets. Pediatr Nephrol 19:473-477
22. Schütt SM, Schumacher M, Holterhus PM, Felgenhauer S, Hiort O (2003) Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency. Eur J Endocrinol 149:317-321
23. Seikaly MG, Brown R, Baum M (1997) The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics 100:879-884
24. Shore RM, Langman CB, Poznanski AK (2000) Lumbar and radial bone mineral density in children and adolescents with X-linked hypophosphatemia: evaluation with dual X-ray absorptiometry. Skeletal Radiol 29:90-93
25. Sochett E, Doria AS, Henriques F, Kooh SW, Daneman A, Makitie O (2004) Growth and metabolic control during puberty in girls with X-linked hypophosphatemic rickets. Horm Res 61:252-256
26. Stamoyannou L, Karachaliou F, Gioureli E, Voskaki E, Mengreli C, Bartsocas CS, Koutselinis A (1997) Effect of growth hormone therapy on bone metabolism of growth hormone deficient children. Eur J Pediatr 156:592-596
27. Steendijk R, Hauspie RC (1992) The pattern of growth and growth retardation of patients with hypophosphataemic vitamin D-resistant rickets: a longitudinal study. Eur J Pediatr 151:422-427
28. Steendijk R, Herweijer TJ (1984) Height, sitting height and leg length in patients with hypophosphatemic rickets. Acta Paediatr Scand 73:181-184
29. Takeda E, Taketani Y, Sawada N, Sato T, Yamamoto H (2004) The regulation and function of phosphate in the human body. Biofactors 21:345-355
30. Wilson DM (2000) Growth hormone and hypophosphatemic rickets. J Pediatr Endocrinol Metab 13 [Suppl 2]:993-998
31. Wilson DM, Lee PD, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG (1991) Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145:1165-1170